BlissCo is currently trading on the following stock exchanges:
Frankfurt Stock Exchange (FRA) as GQ4B:GR
BlissCo Receives Dried Cannabis From Ecosystem Partner Supreme for Sales License Amendment Application to Serve $200 Billion Medical Export Market
Global market for medical cannabis exports predicted to be worth $200 billion
Not for distribution in the U.S. or to U.S. newswire services.
Vancouver, British Columbia – June 25, 2018 – BlissCo Cannabis Corp. (FRA: GQ4B) (CSE: BLIS), (“BlissCo”) is pleased to announce that just days after news of legalization in Canada, the company is receiving a supply of premium dried cannabis from The Supreme Cannabis Company Inc. (TSX.V: FIRE) this week.
This dried cannabis will enable BlissCo to apply for a sales amendment to its ACMPR license for the purpose of supplying its domestic and global ecosystem partners in nations where medical cannabis is federally legal.
“We are right on schedule with the submission of this application to receive an amendment to our ACMPR license to permit us to begin sales in late September,” said Damian Kettlewell, CEO of BlissCo Cannabis Corp. “The transition to significant revenue growth is the key milestone that we have been focused on as we have laid the groundwork for almost five years. We continue to make positive steps towards realizing our vision of creating an iconic Canadian cannabis brand.”
This cannabis will be packaged into five, ten and thirty gram containers which will allow BlissCo to, in mid-July, apply for an amendment to its ACMPR license to allow dried cannabis sales in domestic markets and apply for export permits for international markets.
BlissCo’s Ecosystem has initiated the exploration of business development plans that will continue to develop the company’s global network of strategic alliances, ultimately supporting the company’s efforts to foster relationships in the international market.
"We have been watching the development of BlissCo for some time and have been impressed by Mr. Kettlewell's retail and distribution strength, industry connectivity and vision for the cannabis industry in British Columbia and Western Canada." said John Fowler, CEO of Supreme Cannabis. "Like Supreme, British Columbians have a passion for high-quality cannabis and we look forward to [continuing our work with] Mr. Kettlewell and his team at BlissCo."
On Behalf of the Board of Directors
BLISSCO CANNABIS CORP.
Damian Kettlewell, CEO, Founder & Chair
For further information please contact:
Ariel Jack Lewinski, Business Development & Investor Relations
This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the ability to execute on our strategic plans and the impact on our future operations, capital expenditures, receipt of a cannabis oil license and a license to sell dried cannabis and other objectives. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.
The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.
As Canada is primed as a global leader and first mover in the cannabis industry, BlissCo is uniquely poised in the rapidly growing multi-billion dollar market and in various international markets as cannabis regulations progress.
BlissCo, founded in 2013, is a Canadian vertically integrated cultivation, extraction and distribution focused cannabis brand that earned its Access to Cannabis for Medical Purposes Regulations (ACMPR) license to cultivate from Health Canada on March 29, 2018.
BlissCo's state-of-the-art production facility, located in Metro Vancouver, is purposefully designed as a hub for research, cultivation, processing, extraction, packaging and distribution.
Now with the ACMPR license to cultivate, BlissCo will commence its operation to harvest premium cannabis within its' urban facility in Metro Vancouver. BlissCo also has a multi-year supply agreement in place with a Canadian Licensed Producer of characteristically sun-grown premium medicinal cannabis to purchase supply in large volumes (news release). This premium bulk cannabis will be brought to our secure and pristine facility in British Columbia for processing and then be packaged for sale and distribution to our growing patient list when BlissCo has appropriately received its license for sale.
BlissCo was founded with the assistance of a team of advisors, including medical and naturopathic doctors, has intentionally engaged with the medical community to understand how to contribute to improved patient health with medicinal cannabis products. A large part of our strategy for growth centres on how to securely integrate and collaborate with the healthcare system.
The BlissCo team has deep domain expertise in the critical category success areas:
- Multi-province controlled substance distribution (BC and Alberta)
- Cultivation and product safety, consistency and security
- Indoor cultivation, controlled environments ensuring high standards & consistent products.
- Quality assurance, product safety, 3rd Party GMP Audits & Certifications.
Strategic partnership with the Supreme Cannabis Company
Trading on Canadian Securities Exchange (CSE:BLIS)
ACMPR License to Produce earned
Cannabis plant starting material to arrive at BlissCo's facility and growing commences.
ACMPR Cannabis Oil Extraction License application submitted
Sign agreement to export 720 kilograms of medical cannabis to Germany
ACMPR License to Sell application submitted
Sign supply agreement with GreenSeal Cannabis
Sign e-commerce and technology service agreement with Namaste Technologies (TSXV: N)
Confirmation of Readiness for Inspection received from Health Canada
Confirmation of Readiness for License from Health Canada
Close on purchasing facility for $2.4m
Earn Building Permit from Township of Langley
ACMPR Licensed Submitted